Navigation Links
CR-DGi Non-Mydriatic Retinal Camera

ProductsCR-DGi Non-Mydriatic Retinal Camera
Company Canon Medical Systems
Item CR-DGi Non-Mydriatic Retinal Camera
Features 
  • Quick access to images
  • Superior image quality
  • Easy alighnment & focusing
  • Reduced illumination
  • Description Images captured with the CR-DGi can be viewed immediately, making procedures more efficient. But that's just the beginning. Because the images are digital, they can be used with many different applications, such as telemedicine and electronic filing. The CR-DGi combines the power of digital imaging with quality and ease of use. It's the latest advance from Canon, the pioneer of non-mydriatic retinal cameras.
    Info Canon Medical Systems
    Customer Service: (516) 328-5000
    Web site: http://www.usa.canon.com/html/industrial_medeq/ophthalmic_index.html

    Related medicine products :

    1. ReSeeVit CR-DGi Digital Imaging Sys Cmp
    2. CR6-45NM Non-Mydriatic Retinal Camera
    3. Non-Mydriatic Fundus Camera NM-1000
    4. Hand-Held Non-Mydriatic Fundus Camera NM-200D
    5. TRC-NW200 Non-Mydriatic Retinal Camera
    6. VISUCAMPRO NM™ Non-Mydriatic Fundus Camera System
    7. Gass Retinal Detachment Hook
    8. Olk Angled Retinal Pick - 110 Degree
    9. Olk Angled Retinal Pick - 150 Degree
    10. Olk Angled Retinal Pick - 130 Degree
    11. Weiss Retinal Pick 90 Degree Long
    ... CCR Medical's Articulating Tip Laryngoscopes ... in the Industry. The articulating ... by providing an improved view ... and Fiber Optic styles. We ...
    CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
    ... Medical's Articulating Tip Laryngoscopes are ... the Industry. The articulating tip ... providing an improved view of ... Fiber Optic styles. We guarantee ...
    CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
    Medicine Products:
    (Date:5/20/2013)... May 20, 2013 This summer, digital ... world will make the pilgrimage to San Diego, CA, ... Digital Health Summer Summit produced by Living ... unique forum to showcase the latest digital health innovations, ... and network with some of industry’s most brilliant thinkers ...
    (Date:5/20/2013)... Dennis Thompson HealthDay Reporter , , MONDAY, May ... attention deficit-hyperactivity disorder (ADHD) are twice as likely to ... disorder when they were young, a new 30-year study ... tended to have a higher body-mass index (BMI) and ... the disorder. Socioeconomics made no difference; well-off or ...
    (Date:5/20/2013)... Posterior fossa subdural hematoma (PFSDH) is a serious and ... But with appropriate treatment, there,s an excellent chance of ... reports a study in the May issue of ... Congress of Neurological Surgeons . The journal is published ... of Wolters Kluwer Health . , The results ...
    (Date:5/20/2013)... Wolters Kluwer Health is pleased to announce ... journals won 13 ASHPE awards in 10 categories. ... publications for editorial, design, print and online award ... recognized year after year for delivering high-quality publications ... quality, depth, and impact," said Jayne Marks, Vice ...
    (Date:5/20/2013)... Francisco, CA (PRWEB) May 20, 2013 ... health assistant at HealthBeat 2013. A mobile application called ... the time and effort it takes to arrange for ... Allie offers a unique combination of mobile technology and ... order to help people ensure their health care needs ...
    Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 2Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 3Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 3Health News:Wolters Kluwer Health receives 13 awards from the ASHPE 2Health News:Allayo Debuts Virtual Health Assistant At HealthBeat 2013 2
    ... Nutrisystem, Inc. (Nasdaq: NTRI ), a leading developer ... new multi-year alliance with the American Diabetes Association to ... public about the importance of weight loss for people ... Nutrisystem will support the Association,s efforts to fund both ...
    ... 26 CardioGenics Holdings Inc. (OTC Bulletin Board: JAGH) has ... change for the Company on the OTCBB will take place ... The new ticker symbol for "CardioGenics Holdings Inc." on ... the name and ticker symbol change that is scheduled to ...
    ... , WASHINGTON , Oct. 26 ... Karen Ignagni, President and CEO: , "A new government-run plan would ... down costs and improve quality. The American people want health ... that. , "The divisive debate about a government-run plan ...
    ... LAKE FOREST, Ill., Oct. 26 Akorn, Inc. (Nasdaq: AKRX ) will release third ... conference call on Tuesday, November 10, to discuss quarterly results followed by a Q&A session: , ... Akorn Third Quarter 2009 Conference Call, Date/Time: ... ...
    ... the impact of severe physical, psychosocial suffering, researchers say ... survivors of World War II, those who were potentially ... cancer, likely due to physical and mental stress, an ... compared cancer rates in more than 300,000 Israeli Jews ...
    ... spell trouble, study finds , MONDAY, Oct. 26 (HealthDay News) ... the risk of dangerous blood clots in veins, although that ... indicates. , The 10-year study found that bigger hips are ... women but not men, while a wider waistline was associated ...
    Cached Medicine News:Health News:Nutrisystem and the American Diabetes Association Form a Strategic Alliance to Promote the Importance of Weight Loss for People With Type 2 Diabetes 2Health News:Nutrisystem and the American Diabetes Association Form a Strategic Alliance to Promote the Importance of Weight Loss for People With Type 2 Diabetes 3Health News:AHIP Statement on Government-Run Plan 2Health News:AHIP Statement on Government-Run Plan 3Health News:Exposure to Holocaust May Have Raised Cancer Risks 2Health News:Where You Put on Pounds May Influence Clot Risk 2
    (Date:5/20/2013)... 2013  Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical ... unique technology to deter prescription drug abuse today ... Anthony Soscia , has been chosen as ... ,s Health-Care Heroes Awards. The awards are presented ... to honor individuals and organizations demonstrating excellence and deserving ...
    (Date:5/20/2013)... SAN DIEGO , May 20, 2013 ... in Elcelyx Therapeutics, Phase 2b dose-finding clinical trial of ... generic metformin, the foundational treatment for Type 2 diabetes. ... the multicenter U.S. program in June. Results of the ... are expected in late summer, and the read-out for ...
    (Date:5/20/2013)... , May 20, 2013  Neuralstem, Inc. (NYSE ... , MD, PhD, principal investigator, presented updated Phase ... cell (NSI-566) trial in the treatment of amyotrophic lateral ... disease) at the neuro diabetes special medical symposium in ... a talk called "Recent Therapeutic Advances in Stem Cell ...
    Breaking Medicine Technology:Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4